olmesartan has been researched along with pd 123319 in 9 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (pd 123319) | Trials (pd 123319) | Recent Studies (post-2010) (pd 123319) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 894 | 6 | 175 |
| Protein | Taxonomy | olmesartan (IC50) | pd 123319 (IC50) |
|---|---|---|---|
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.21 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.21 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.21 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, M; Hirano, T; Ran, J | 1 |
| Adachi, M; Fukui, T; Hirano, T; Kageyama, H; Okada, K; Ran, J; Saito, K | 1 |
| Hashizume, K; Nakamura, J; Shigematsu, S; Takeuchi, Y; Yamauchi, K | 1 |
| Carl-McGrath, S; Ebert, MP; Lendeckel, U; Röcken, C | 1 |
| Hashimoto, K; Horino, T; Inoue, K; Kagawa, T; Matsumoto, R; Morita, T; Takao, T | 1 |
| Ichihara, K; Kaneta, S; Kano, S; Satoh, K | 1 |
| Fujimura, M; Ichikawa, Y; Inuzuka, K; Nakao, S; Nishizawa, Y; Tagami, A; Takato, H; Waseda, Y; Yasui, M | 1 |
| Adachi, Y; Harada, M; Horiuchi, M; Kinoshita, H; Kishimoto, I; Kuwahara, K; Li, Y; Murray, M; Nakanishi, M; Nakao, K; Rong, X; Saito, Y | 1 |
| Clifford, PS; Davis, MJ; Hill, MA; Hong, K; Hong, Z; Meininger, GA; Sun, Z; Yang, Y; Zhao, G | 1 |
9 other study(ies) available for olmesartan and pd 123319
| Article | Year |
|---|---|
Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Fatty Acids, Nonesterified; Imidazoles; Liver; Male; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Triglycerides; Vasoconstrictor Agents | 2005 |
Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
Topics: Adiponectin; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucose Tolerance Test; Hypertension; Imidazoles; Injections, Subcutaneous; Insulin; Insulin Resistance; Leptin; Male; Oligopeptides; Pyridines; Rats; Rats, Wistar; Receptors, Adiponectin; Receptors, Cell Surface; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Angiotensin II regulates migration in mouse cultured mesangial cells: evidence for the presence of receptor subtype-specific regulation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Cell Movement; Cell Proliferation; Cells, Cultured; Imidazoles; Immunoblotting; Mesangial Cells; Mice; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 2006 |
Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 2 Receptor Blockers; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enalapril; Female; Gene Expression Regulation, Neoplastic; Genotype; Humans; Imidazoles; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Peptidyl-Dipeptidase A; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms; Tetrazoles | 2007 |
Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Apoptosis; Caspase 3; Caspase 7; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Enzyme Activation; Epithelial Cells; Glucosamine; Humans; Imidazoles; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; NADPH Oxidases; Pyridines; Receptor, Angiotensin, Type 2; Receptors, Tumor Necrosis Factor, Type I; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2008 |
Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Dogs; Female; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardial Stunning; Myocardium; Pyridines; Receptor, Angiotensin, Type 2; Tetrazoles | 2008 |
Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bleomycin; Blood Cell Count; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Hydroxyproline; Imidazoles; Macrophage Inflammatory Proteins; Male; Mice; Mice, Inbred ICR; Pulmonary Fibrosis; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2008 |
Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Body Weight; Cardiomegaly; Collagen; Heart; Imidazoles; Immunoblotting; Male; Mice; Mice, Knockout; Myocardium; Organ Size; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Atrial Natriuretic Factor; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Vasoconstrictor Agents | 2009 |
Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles.
Topics: Abdominal Muscles; Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterioles; Benzimidazoles; Biphenyl Compounds; Captopril; Cells, Cultured; Diglycerides; Imidazoles; Indoles; Losartan; Male; Maleimides; Muscle Development; Muscle Fibers, Skeletal; Pressure; Protein Kinase C; Pyridines; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 2016 |